Aandeel JPH JERUSALEM PHARMACEUTICALS CO. LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
PDF-rapport : Jerusalem Pharmaceuticals Co. Ltd.

Andere talen Jerusalem Pharmaceuticals Co. Ltd.

Aandelen

JPH

PS2016112695

slotkoers Palestine Exchange
Andere beurzen
 00:00:00 23-11-2023 		Intraday-grafiek van Jerusalem Pharmaceuticals Co. Ltd. Variatie 5 dagen Verschil t.o.v. 1 jan (%)
3,600 USD +1,41% -.--% +9,76%
10/08 Jerusalem Pharmaceuticals Co. Ltd. Rapporteert winstresultaten voor het tweede kwartaal en de zes maanden eindigend op 30 juni 2023 CI
14/05 Jerusalem Pharmaceuticals Co. Ltd. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2023 CI

Andere talen

Zoeken op
Ontgrendel al het nieuws over alle bedrijven: Mis nooit meer een winstgevende investeringskans!
Gratis inschrijven
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2019
Jerusalem Pharmaceuticals Co. Ltd. Approves Dividend for the Year 2018, Payable on 21 June 2019
Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2018
Jerusalem Pharmaceuticals Co. Ltd. Reports Consolidated Unaudited Earnings Results for the Year Ended December 31, 2018
Jerusalem Pharmaceuticals Co. Ltd. Reports Unaudited Earnings Results for the Nine Months Ended September 30, 2018
Jerusalem Pharmaceuticals Co. Ltd. Reports Consolidated Earnings Results for the First Half of 2018
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018
Jerusalem Pharmaceuticals Co. Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2017
Jerusalem Pharmaceuticals Co. Ltd. Announces Unaudited Earnings Results for the Full Year Ended December 31, 2017
Jerusalem Pharmaceuticals Co. Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2014
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel Artikel MarketScreener Analyse MarketScreener

Filters

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Aandeel Jerusalem Pharmaceuticals Co. Ltd. - Palestine Exchange
  4. Nieuws Jerusalem Pharmaceuticals Co. Ltd.
  5. Andere talen
De beste beleggingen van morgen voortaan makkelijk te vinden!
Mijn winst optimaliseren
fermer
Etats-Unis

MarketScreener est aussi disponible en United States

Changer d'édition
Ik blijf hier.